Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Medical Imaging Phantoms Market Size & Growth Forecast 2026–2035, By Segments (End-use, Application, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11606| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Medical Imaging Phantoms Market size was estimated at USD 188.59 Million in 2025 and is projected to grow at a 6% CAGR from 2026 to 2035, reaching USD 337.74 Million by 2035. The industry revenue for 2026 is assessed at USD 198.44 million.

Base Year Value (2025)
USD 188.59 Million
CAGR (2026-2035)
6%
Forecast Year Value (2035)
USD 337.74 Million
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Medical Imaging Phantoms Market Intelligence Snapshot

Regional Market Dynamics

  • North America accounted for 38.58% of the market in 2025, supported by advanced imaging facilities and routine use of phantoms for calibration, quality assurance, and training.
  • Asia Pacific is expected to expand at a 6.78% CAGR due to increasing diagnostic imaging capacity, broader technology adoption, and growing demand for quality control and operator training tools.

Segment Momentum

  • Hospitals and diagnostic imaging centers hold 59.12% share due to continuous use in calibration, performance checks, and image quality validation across high-volume clinical imaging workflows.
  • Medical device manufacturers are driving fast growth due to increased reliance on phantoms for testing, validation, and benchmarking of imaging systems during development and commercialization stages.

Market Expansion Drivers

  • Increasing chronic disease burden driving demand for precise diagnostic imaging calibration solutions.
  • Rising healthcare investments in advanced imaging technologies increasing phantom utilization for quality assurance.
  • Technological advancements in MRI and CT phantoms enhancing imaging accuracy and testing reliability.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Key players in the medical imaging phantoms market include Kyoto Kagaku Co., Ltd. (Japan), Mirion Technologies, Inc. (United States), PTW Freiburg GmbH (Germany), Sun Nuclear Corporation (United States), Modus Medical Devices Inc. (Canada), Gold Standard Phantoms (United Kingdom), Leeds Test Objects Ltd. (United Kingdom), RSD Radiology Support Devices, Inc. (United States), IBA Worldwide (Belgium).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Increasing chronic disease burden increasing demand for precise diagnostic imaging calibration solutions

As chronic diseases such as cancer, cardiovascular disorders, and neurological conditions account for a larger share of diagnostic workloads, imaging departments are under greater pressure to produce consistently accurate scans that can support early detection, treatment planning, and follow-up assessment. This is strengthening demand in the medical imaging phantoms market because providers rely on phantoms to calibrate and validate imaging systems used repeatedly for high-volume, high-stakes examinations. In practice, rising chronic disease case loads increase the frequency of quality checks, protocol standardization, and performance verification in modalities such as CT, MRI, and ultrasound, reinforcing market demand for phantoms that help reduce variability and support dependable image interpretation.

Rising healthcare investments in advanced imaging technologies increasing phantom utilization for quality assurance

Capital spending on newer imaging systems is expanding the installed base of sophisticated scanners in hospitals, diagnostic centers, and specialty clinics, which directly supports growth in the medical imaging phantoms market. Each new modality deployment typically brings stricter acceptance testing, routine quality assurance, and staff training requirements, making phantom use a practical part of equipment commissioning and ongoing performance monitoring. As healthcare providers invest in higher-resolution and more complex imaging platforms, they also need more specialized phantom solutions to verify image quality, align protocols, and maintain compliance with internal and regulatory quality standards, contributing to market size growth through recurring utilization rather than one-time purchases alone.

Technological advancements in MRI and CT phantoms enhancing imaging accuracy and testing reliability

Ongoing design improvements in phantom materials, anatomical realism, and modality-specific testing capabilities are making these products more useful in daily imaging operations, which is influencing adoption in the medical imaging phantoms market. More advanced MRI and CT phantoms allow imaging teams to assess parameters such as contrast performance, spatial resolution, dose optimization, and artifact behavior with greater consistency, giving clinicians and physicists more confidence in scanner output before patient use. This practical improvement in testing reliability is encouraging market growth as buyers increasingly favor phantom systems that match the technical complexity of modern imaging equipment and fit into stricter quality control workflows.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing chronic disease burden driving demand for precise diagnostic imaging calibration solutions 1.80% High North America, Asia Pacific High Near Term
Rising healthcare investments in advanced imaging technologies increasing phantom utilization for quality assurance 1.70% High North America, Europe High Mid Term
Technological advancements in MRI and CT phantoms enhancing imaging accuracy and testing reliability 1.40% Moderate Asia Pacific, Europe Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
38.58% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 38.58% share of the medical imaging phantoms market in 2025, backed by its dense concentration of advanced diagnostic imaging facilities, established quality assurance protocols, and routine use of phantoms in equipment calibration, performance testing, and training. The region’s leadership is reinforced by consistent adoption across hospitals, imaging centers, and research institutions, where maintaining image accuracy and compliance with clinical standards directly drives recurring demand for specialized phantom products.

Asia Pacific is projected to expand at a 6.78% CAGR over the forecast period, with growth in the medical imaging phantoms market being propelled by the ongoing build-out of diagnostic imaging capacity and broader adoption of imaging technologies across healthcare systems. Demand is accelerating as providers invest in newer imaging equipment and require phantoms for acceptance testing, quality control, and operator training, while the region’s expanding clinical infrastructure is creating a larger practical base of end users for these products.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Quality Assurance

Germany emphasizes high-precision medical imaging phantoms for equipment testing, calibration, and regulatory compliance across healthcare facilities. German imaging centers and manufacturers prioritize reproducible performance standards that enhance diagnostic accuracy and system verification.

France 🇫🇷

Standardized Imaging Evaluation

France prioritizes medical imaging phantoms that enable dependable quality assurance across radiology departments and research institutions. Healthcare organizations in France continue adopting standardized testing procedures to maintain imaging reliability and support equipment performance assessment.

Italy 🇮🇹

Healthcare Equipment Calibration

Italy relies on medical imaging phantoms to improve calibration, maintenance, and performance verification for diagnostic imaging systems. Hospitals and imaging centers in Italy emphasize dependable testing solutions that contribute to consistent image quality and effective clinical workflows.

Japan 🇯🇵

Diagnostic Accuracy Support

Japan utilizes medical imaging phantoms to strengthen imaging quality across advanced diagnostic systems and clinical research applications. Healthcare providers in Japan focus on reliable calibration tools that support consistent imaging performance and technical evaluation.

South Korea 🇰🇷

Clinical Imaging Optimization

South Korea expands the use of medical imaging phantoms as healthcare providers modernize diagnostic imaging capabilities. The market in South Korea values standardized testing solutions that improve equipment validation, staff training, and imaging consistency across clinical settings.

United States 🇺🇸

Advanced Imaging Validation

The U.S. medical imaging phantoms market supports hospitals, research institutions, and equipment manufacturers seeking accurate imaging calibration and quality assurance. Organizations in the U.S. increasingly require specialized phantoms compatible with advanced diagnostic imaging technologies and clinical validation protocols.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Medical Imaging Phantoms Market Share (%), End-use, 2025

Hospitals & Diagnostic Imaging Centers
Medical Device Manufacturers
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End-use Segment Analysis: Hospitals & Diagnostic Imaging Centers (Largest Segment) vs Medical Device Manufacturers (Fastest-Growing Segment)

Hospitals & Diagnostic Imaging Centers accounted for a 59.12% share of the medical imaging phantoms market in 2025, reflecting their central role in routine imaging workflows and equipment validation. This segment maintains leadership because phantoms are used repeatedly in day-to-day calibration, performance checks, and image quality verification across busy clinical environments. The consistent need to keep imaging systems operating within required standards sustains purchasing demand from hospitals and diagnostic imaging centers, where utilization volumes are higher and quality control procedures are more embedded than in most other end-use settings.

Medical Device Manufacturers represent the fastest-growing end-use segment in the medical imaging phantoms market as development activity increasingly depends on controlled testing environments for system design, validation, and performance benchmarking. Growth is being supported by the practical need to evaluate new imaging technologies under repeatable conditions before commercialization and deployment. Compared with clinical buyers that often purchase around established operating cycles, manufacturers are gaining momentum because phantom use is tied directly to product development pipelines and testing requirements, creating a stronger expansion dynamic for this segment.

Application Segment Analysis: Calibration & Quality Assurance (Largest Segment) vs Diagnostic Imaging (Fastest-Growing Segment)

In 2025, Calibration & Quality Assurance held a 40.6% share of the medical imaging phantoms market, supported by the essential role phantoms play in maintaining imaging accuracy and system consistency. This application leads because calibration and quality assurance are recurring operational requirements rather than occasional uses, making demand more stable across imaging facilities. In the medical imaging phantoms market, the need to verify equipment performance, standardize output, and support dependable image quality keeps this segment firmly ahead of other applications.

Diagnostic Imaging is the fastest-growing application in the medical imaging phantoms market, encouraged by increasing reliance on realistic test objects to assess imaging performance under conditions that closely reflect clinical use. Its momentum comes from the need to support better image interpretation, protocol refinement, and system evaluation as imaging practices become more demanding. Relative to calibration-focused use, which is already deeply established, diagnostic imaging is expanding faster because it aligns more directly with evolving imaging requirements and broader use of phantoms in practical scan assessment.

Segment Sub-Segment Largest Segment Fastest Growing
End-use Hospitals & Diagnostic Imaging Centers, Medical Device Manufacturers, Others Hospitals & Diagnostic Imaging Centers Medical Device Manufacturers
Application Calibration & Quality Assurance, Diagnostic Imaging, Research & Development, Training & Education, Therapeutic Applications Calibration & Quality Assurance Diagnostic Imaging
Product CT (Computed Tomography) Phantoms, MRI (Magnetic Resonance Imaging) Phantoms, Ultrasound Phantoms, X-ray Phantoms, Nuclear Medicine Phantoms, Others CT (Computed Tomography) Phantoms MRI (Magnetic Resonance Imaging) Phantoms
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the medical imaging phantoms market:

1. Kyoto Kagaku Co. Ltd. (Japan)

2. Mirion Technologies Inc. (United States)

3. PTW Freiburg GmbH (Germany)

4. Sun Nuclear Corporation (United States)

5. Modus Medical Devices Inc. (Canada)

6. Gold Standard Phantoms (United Kingdom)

7. Leeds Test Objects Ltd. (United Kingdom)

8. RSD Radiology Support Devices Inc. (United States)

9. IBA Worldwide (Belgium)

The medical imaging phantoms market is witnessing steady innovation as developers focus on enhancing simulation accuracy and compatibility with advanced imaging modalities. Research-driven product improvements are enabling more precise calibration, testing, and training applications across healthcare facilities. Growing emphasis on quality assurance in diagnostic imaging is also contributing to the adoption of highly specialized phantom solutions.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Siemens Healthineers Dec-24 Siemens Healthineers expanded its Magnetom Flow 1.5T MRI platform with a 70-centimeter bore scanner designed to improve patient comfort, imaging quality, sustainability, and workflow automation. The enhancement supports advanced diagnostic imaging environments and reinforces demand for higher-precision calibration and validation tools, including medical imaging phantoms.
RSD Radiology Support Devices Jul-24 RSD Radiology Support Devices announced the upcoming launch of multimodality phantoms designed for CT, MRI, and X-ray systems. The development aims to improve diagnostic accuracy and system calibration across imaging modalities, supporting more reliable quality assurance and performance validation in clinical radiology workflows.
Festo Jun-24 Festo acquired Carville’s process technologies and production facilities focused on multilayer plastic manifolds, with production planned to begin in 2025. The acquisition strengthens Festo’s capabilities in laboratory automation and medical technology components, indirectly supporting advanced manufacturing solutions relevant to precision medical imaging systems and associated calibration technologies.
Philips Feb-24 Philips launched the AI-enabled CT 5300 at ECR 2024, enhancing diagnostic imaging capabilities and workflow efficiency. The system supports more advanced clinical decision-making in complex cases such as cardiac imaging, driving increased demand for high-accuracy calibration tools and medical imaging phantoms used in system validation and performance optimization.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Medical Imaging Phantoms Market — Custom Segments

Segment Sub-Segment
No segment data available.

Medical Imaging Phantoms Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the medical imaging phantoms market?

In 2026 the market for medical imaging phantoms is valued at USD 198.44 million.

What is the anticipated CAGR of the medical imaging phantoms industry?

Medical Imaging Phantoms Market size is anticipated to rise from USD 188.59 million in 2025 to USD 337.74 million by 2035 reflecting a CAGR surpassing 6% over the forecast horizon of 2026-2035.

How are healthcare investments in advanced imaging systems influencing demand for medical imaging phantoms?

Investments in advanced imaging equipment are increasing acceptance testing, routine quality assurance, and staff training requirements, driving recurring demand for specialized phantoms that support equipment commissioning, protocol alignment, and ongoing performance verification.

Why are advanced MRI and CT phantoms becoming increasingly important in imaging quality assurance?

Improved phantom designs enable more consistent assessment of image quality, spatial resolution, contrast performance, dose optimization, and artifact behavior, helping imaging teams maintain reliable scanner performance within increasingly rigorous quality control workflows.

Why do hospitals and diagnostic imaging centers dominate the medical imaging phantoms market?

Hospitals and diagnostic imaging centers hold 59.12% share due to continuous use in calibration, performance checks, and image quality validation across high-volume clinical imaging workflows.

What is fueling demand from medical device manufacturers?

Medical device manufacturers are driving fast growth due to increased reliance on phantoms for testing, validation, and benchmarking of imaging systems during development and commercialization stages.

What makes North America the leading market for medical imaging phantoms?

North America accounted for 38.58% of the market in 2025, supported by advanced imaging facilities and routine use of phantoms for calibration, quality assurance, and training.

Why is Asia Pacific emerging as a growth market for medical imaging phantoms?

Asia Pacific is expected to expand at a 6.78% CAGR due to increasing diagnostic imaging capacity, broader technology adoption, and growing demand for quality control and operator training tools.

Who are the major participants shaping the medical imaging phantoms landscape?

Key players in the medical imaging phantoms market include Kyoto Kagaku Co., Ltd. (Japan), Mirion Technologies, Inc. (United States), PTW Freiburg GmbH (Germany), Sun Nuclear Corporation (United States), Modus Medical Devices Inc. (Canada), Gold Standard Phantoms (United Kingdom), Leeds Test Objects Ltd. (United Kingdom), RSD Radiology Support Devices, Inc. (United States), IBA Worldwide (Belgium).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →